Works matching IS 11727047 AND DT 2025 AND VI 39


Results: 62
    1

    Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.

    Published in:
    CNS Drugs, 2025, v. 39, n. 7, p. 693, doi. 10.1007/s40263-025-01191-7
    By:
    • Novi, Giovanni;
    • Bovis, Francesca;
    • Sciolla, Chiara;
    • Frau, Jessica;
    • Minetti, Matteo;
    • Napoli, Francesca;
    • Vianello, Marika;
    • Greco, Giacomo;
    • Sechi, Elia;
    • Bellomo, Andrea;
    • Garelli, Paola;
    • Spiezia, Antonio Luca;
    • Fantozzi, Roberta;
    • Schirò, Giuseppe;
    • Ghezzi, Laura;
    • Zecca, Chiara;
    • Signoriello, Elisabetta;
    • Brambilla, Laura;
    • Lucchini, Matteo;
    • Bonavita, Simona
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    18
    19
    20
    21
    22

    Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis: A Time-Based Analysis from the CNB Italian EAP: R. Roberti et al.

    Published in:
    CNS Drugs, 2025, v. 39, n. 5, p. 513, doi. 10.1007/s40263-025-01166-8
    By:
    • Roberti, Roberta;
    • Di Gennaro, Gianfranco;
    • Cianci, Vittoria;
    • D'Aniello, Alfredo;
    • Di Bonaventura, Carlo;
    • Di Gennaro, Giancarlo;
    • Fortunato, Francesco;
    • Fronzoni, Edoardo;
    • Morano, Alessandra;
    • Pascarella, Angelo;
    • Rosati, Eleonora;
    • Sammarra, Ilaria;
    • Russo, Emilio;
    • Lattanzi, Simona
    Publication type:
    Article
    23

    Comparative Effectiveness of Different Opioid Regimens, in Daily Dose or Treatment Duration, Prescribed at Surgical Discharge: a Systematic Review and Meta-Analysis: Comparative Effectiveness of Different Opioid Regimens Prescribed at Surgical Discharge: M. Jamshidi et al

    Published in:
    CNS Drugs, 2025, v. 39, n. 4, p. 345, doi. 10.1007/s40263-025-01165-9
    By:
    • Jamshidi, Masoud;
    • Jones, Caitlin M. P.;
    • Langford, Aili V.;
    • Patanwala, Asad E.;
    • Liu, Chang;
    • Harris, Ian A.;
    • Wale, Janney;
    • Horsley, Mark;
    • Adie, Sam;
    • Jenkin, Deanne E.;
    • Lin, Chung-Wei Christine
    Publication type:
    Article
    24

    Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study: De-escalation in MS: J. Müller et al.

    Published in:
    CNS Drugs, 2025, v. 39, n. 4, p. 403, doi. 10.1007/s40263-025-01164-w
    By:
    • Müller, Jannis;
    • Sharmin, Sifat;
    • Lorscheider, Johannes;
    • Horakova, Dana;
    • Kubala Havrdova, Eva;
    • Eichau, Sara;
    • Patti, Francesco;
    • Grammond, Pierre;
    • Buzzard, Katherine;
    • Skibina, Olga;
    • Prat, Alexandre;
    • Girard, Marc;
    • Grand'Maison, Francois;
    • Alroughani, Raed;
    • Lechner-Scott, Jeannette;
    • Spitaleri, Daniele;
    • Barnett, Michael;
    • Cartechini, Elisabetta;
    • Sa, Maria Jose;
    • Gerlach, Oliver
    Publication type:
    Article
    26
    27

    Disparities in Access to Reperfusion Therapy for Acute Ischemic Stroke (DARTS): A Comprehensive Meta-Analysis of Ethnicity, Socioeconomic Status, and Geographical Factors: Disparities in Acute Reperfusion Therapy: R. Biswas et al.

    Published in:
    CNS Drugs, 2025, v. 39, n. 4, p. 417, doi. 10.1007/s40263-025-01161-z
    By:
    • Biswas, Raisa;
    • Wijeratne, Tissa;
    • Zelenak, Kamil;
    • Huasen, Bella B.;
    • Iacobucci, Marta;
    • Killingsworth, Murray C.;
    • Beran, Roy G.;
    • Gebreyohanns, Mehari;
    • Sekhar, Alakendu;
    • Khurana, Dheeraj;
    • Nguyen, Thanh N.;
    • Jabbour, Pascal M.;
    • Bhaskar, Sonu M. M.
    Publication type:
    Article
    28
    29
    31
    33
    34
    35
    36
    37

    Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study: CNB in Focal Epilepsies: A. Strzelczyk et al.

    Published in:
    CNS Drugs, 2025, v. 39, n. 3, p. 321, doi. 10.1007/s40263-025-01158-8
    By:
    • Strzelczyk, Adam;
    • von Podewils, Felix;
    • Hamer, Hajo M.;
    • Knake, Susanne;
    • Rosenow, Felix;
    • Klotz, Kerstin Alexandra;
    • Kurlemann, Gerhard;
    • Melzer, Nico;
    • Buhleier, Elisa;
    • Mann, Catrin;
    • Willems, Laurent M.;
    • Zöllner, Johann Philipp;
    • Gaida, Bernadette;
    • Cuny, Jeanne;
    • Bellaire, David;
    • Immisch, Ilka;
    • Kämppi, Leena;
    • Brunklaus, Andreas;
    • Schubert-Bast, Susanne
    Publication type:
    Article
    40
    41
    42
    43
    45

    Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial: Evolocumab in Prevention of Early Neurological Deterioration Following Ischemic Stroke: W. Tan et al

    Published in:
    CNS Drugs, 2025, v. 39, n. 2, p. 197, doi. 10.1007/s40263-024-01145-5
    By:
    • Tian, Wen;
    • Cao, Hua;
    • Li, Xidan;
    • Gong, Xing;
    • Yu, Xinting;
    • Li, Dongyun;
    • Xie, Jing;
    • Bai, Ying;
    • Zhang, Dawei;
    • Li, Xiaohong;
    • Xu, Ping;
    • Liu, Jiahui;
    • Zhang, Bingwei;
    • Ji, Xiaofei;
    • Dong, Huijie
    Publication type:
    Article
    47

    Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS: V. Li et al.

    Published in:
    CNS Drugs, 2025, v. 39, n. 3, p. 305, doi. 10.1007/s40263-024-01153-5
    By:
    • Li, Vivien;
    • McKay, Fiona C.;
    • Tscharke, David C.;
    • Smith, Corey;
    • Khanna, Rajiv;
    • Lechner-Scott, Jeannette;
    • Rawlinson, William D.;
    • Lloyd, Andrew R.;
    • Taylor, Bruce V.;
    • Morahan, Julia M.;
    • Steinman, Lawrence;
    • Giovannoni, Gavin;
    • Bar-Or, Amit;
    • Levy, Michael;
    • Drosu, Natalia;
    • Potter, Andrew;
    • Caswell, Nigel;
    • Smith, Lynne;
    • Brady, Erin C.;
    • Frost, Bruce
    Publication type:
    Article
    48
    49
    50

    Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): MPH-MR in Chinese Children and Adolescents with ADHD: Y. Zheng et al

    Published in:
    CNS Drugs, 2025, v. 39, n. 3, p. 289, doi. 10.1007/s40263-024-01136-6
    By:
    • Zheng, Yi;
    • Liu, Huaqing;
    • Wang, Xiuxia;
    • Li, Haibo;
    • Ruhmann, Michaela;
    • Mayer, Anke;
    • Dangel, Oliver;
    • Ammer, Richard
    Publication type:
    Article